Beskrovnaya Oxana's most recent trade in Dyne Therapeutics Inc was a trade of 2,153 Common Stock done at an average price of $11.4 . Disclosure was reported to the exchange on March 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.38 per share. | 11 Mar 2025 | 2,153 | 195,840 | - | 11.4 | 24,501 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 11.83 per share. | 05 Mar 2025 | 1,094 | 197,993 | - | 11.8 | 12,942 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.95 per share. | 18 Feb 2025 | 2,598 | 199,087 | - | 13.9 | 36,242 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.12 per share. | 11 Dec 2024 | 2,334 | 201,685 | - | 28.1 | 65,632 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 62,400 | 62,400 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 39,100 | 176,619 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2024 | 27,400 | 204,019 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 18 Nov 2024 | 2,856 | 137,519 | - | 28.2 | 80,539 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.55 per share. | 18 Sep 2024 | 2,339 | 140,375 | - | 34.5 | 80,812 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.89 per share. | 11 Sep 2024 | 2,161 | 142,714 | - | 31.9 | 68,914 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 45.01 per share. | 19 Aug 2024 | 2,340 | 145,171 | - | 45.0 | 105,323 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 46.00 per share. | 19 Aug 2024 | 296 | 144,875 | - | 46 | 13,616 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.34 per share. | 11 Jun 2024 | 2,136 | 147,511 | - | 31.3 | 66,942 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 20 May 2024 | 30,426 | 180,073 | - | 1.0 | 31,339 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2024 | 30,426 | 0 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.49 per share. | 20 May 2024 | 17,134 | 162,939 | - | 32.5 | 556,684 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 33.51 per share. | 20 May 2024 | 12,147 | 150,792 | - | 33.5 | 407,046 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 34.08 per share. | 20 May 2024 | 1,145 | 149,647 | - | 34.1 | 39,022 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.20 per share. | 16 May 2024 | 2,222 | 150,130 | - | 28.2 | 62,660 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 16 May 2024 | 483 | 149,647 | - | 28.6 | 13,809 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.70 per share. | 11 Mar 2024 | 2,081 | 152,352 | - | 25.7 | 53,482 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 25.85 per share. | 07 Mar 2024 | 2,373 | 154,433 | - | 25.8 | 61,342 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 45,326 | 53,100 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 45,326 | 221,911 | - | 1.0 | 46,686 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.13 per share. | 03 Jan 2024 | 42,453 | 156,806 | - | 18.1 | 769,673 | Common Stock |
| Dyne Therapeutics Inc | Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.05 per share. | 03 Jan 2024 | 24,583 | 181,946 | - | 19.0 | 468,306 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.03 per share. | 03 Jan 2024 | 22,674 | 199,259 | - | 1.0 | 23,354 | Common Stock |
| Dyne Therapeutics Inc | Beskrovnaya Oxana | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2024 | 22,674 | 30,426 | - | - | Stock option (right to buy) | |
| Dyne Therapeutics Inc | Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.34 per share. | 03 Jan 2024 | 15,382 | 206,529 | - | 18.3 | 282,106 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 20.50 per share. | 03 Jan 2024 | 5,361 | 176,585 | - | 20.5 | 109,901 | Common Stock |
| Dyne Therapeutics Inc | Beskrovnaya Oxana | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.72 per share. | 11 Dec 2023 | 1,467 | 176,585 | - | 10.7 | 15,726 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 93,718 | 178,052 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 36,495 | 36,495 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.41 per share. | 18 Sep 2023 | 1,436 | 84,334 | - | 9.4 | 13,513 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.41 per share. | 12 Sep 2023 | 1,484 | 85,770 | - | 10.4 | 15,448 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.43 per share. | 13 Jun 2023 | 1,475 | 87,254 | - | 12.4 | 18,334 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.33 per share. | 14 Mar 2023 | 1,416 | 88,729 | - | 13.3 | 18,875 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 63,000 | 63,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 40,000 | 90,825 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.87 per share. | 09 Dec 2022 | 680 | 90,145 | - | 10.9 | 7,392 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 13.70 per share. | 20 Sep 2022 | 1,413 | 50,825 | - | 13.7 | 19,358 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 14.05 per share. | 15 Sep 2022 | 712 | 52,238 | - | 14.1 | 10,004 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jul 2022 | 23,477 | 23,477 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 4.95 per share. | 14 Jun 2022 | 726 | 52,950 | - | 5.0 | 3,594 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.73 per share. | 11 Mar 2022 | 693 | 53,676 | - | 8.7 | 6,050 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 54,786 | 54,786 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2021 | 36,524 | 54,369 | - | 0 | Common Stock | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 20 Sep 2021 | 827 | 17,845 | - | 16.1 | 13,323 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.61 per share. | 20 Sep 2021 | 617 | 18,672 | - | 15.6 | 9,631 | Common Stock |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 110,000 | 110,000 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 59,857 | 59,857 | - | - | Stock Option (right to buy) | |
| Dyne Therapeutics Inc | Oxana Beskrovnaya | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2020 | 19,289 | 19,289 | - | 0 | Common Stock |